Efficacy and Safety of Switching to Pasireotide in Patients...

Efficacy and Safety of Switching to Pasireotide in Patients With Acromegaly Controlled With Pegvisomant and First-Generation Somatostatin Analogues (PAPE Study)

Muhammad, Ammar, van der Lely, Aart J, Delhanty, Patric J D, Dallenga, Alof H G, Haitsma, Iain K, Janssen, Joseph A M J L, Neggers, Sebastian J C M M
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
103
Language:
english
Journal:
The Journal of Clinical Endocrinology & Metabolism
DOI:
10.1210/jc.2017-02017
Date:
February, 2018
File:
PDF, 528 KB
english, 2018
Conversion to is in progress
Conversion to is failed